Rick,
But imagine for a moment that the wheat/barley-targeted engineered versions of TRIr you are now working with (or PDR5 or anything else)do in fact prove useful and warrant inclusion in cultivars. That proof is several years away. If we wait for confirmation to initiate plant breeding efforts to deploy those constructs, we will have lost several years [because we could start deployment now]. If we start deploying them now and they prove inadequate, we will have wasted the breeding resources involved. This represents two 'errors' or loss scenarios-
- We are cautious and await proof of function, and start deployment three??
years after the gene was available 2) We proceed with deployment only to learn that the gene fails to meet our needs.
To me, the second kind of error is miniscule in cost compared to the first.
You've correctly pointed out a sticky fundamental strategey question; i.e., how soon to put transgenes into a breeding program? I see it as the type of question that has no fixed answer but is determined on a case by case evaluation of resources, priorities, individual program preferences, etc. My own predilection is to at least get some indication of resistance before recommending inclusion into a breeding program - to avoid wasting effort on ineffective transgenes. However, this is really a decision of the breeding programs and consideration by the Scab Initiative Steering committee. Labs like ours can transform, confirm whether the transgene is present, and continue to characterize the transgenic line, but moving into testing and when to include in breeding programs are decisions others must make (and with whom we would fully cooperate).
exactly how would the step 2 take place? Transform all elite varieties? Through sexual hybridization and conventional breeding?
There are still certain cultivars that transform relatively easily (we still use Bobwhite) while others are almost totally recalcitrant. What might be possible is an identification of a small set of elite lines acceptable to many different programs and which are transformable with reasonable effort. This would take some effort and resources to establish. All this assumes the current technology and could change with new advances.
I see the newly available TRIr gene as an opportunity to facilitate maturation of the genetic part of the initiative into a fine-tuned deployment system. I propose we declare TRIr (and other transgenes??) a target for development and testing of a gene deployment system. In some sense I'm suggesting a 'war game' where we assume TRIr is a useful gene. It may turn out to be a dry-run, but we will have addressed in a real world manner the logistical and organizational hurdles that are difficult to imagine, let alone conquer. (and of course if TRIr works, not an entirely unlikely scenario, we will have achieved our goal of enhancement of in-farm resistance levels in the shortest period of time possible).
Viewing the TRIr gene (and possibly a few others) as an experiment in speed of deployment certainly has merit - as long as we all understand that any specific gene is likely to fail - that's why we need to try as many as possible. The TRIr gene has the right "feel" of something that could work, but we don't want to mislead growers and agencies into thinking it's more of a sure thing than it is. But, I think I agree that the TRIr gene (or some others coming along in different labs) could be used to test transgene utilization so we have a clearer idea how all of this will actually work.
Olin Anderson